LCM
MDT icon

Legato Capital Management’s Medtronic MDT Stock Holding History

Legato Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,945
Closed -$1.11M – 274
2021
Q2 		$1.11M Buy
+8,945
New +$1.12M 0.16% 148

Other funds holding MDT

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Legato Capital Management's MDT Position: Q3 2021 in Review

Legato Capital Management sold out of Medtronic (MDT) in Q3 2021, closing a stake of 8,945 shares — an estimated $1.11M sold.

Legato Capital Management first reported a position in MDT in Q2 2021 and held it in 1 quarter. The position peaked at $1.11M in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Legato Capital Management reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • Legato Capital Management sold 8,945 Medtronic shares in Q3 2021, an estimated $1.11M.
  • Legato Capital Management first reported a position in Medtronic in Q2 2021 and held it in 1 quarter.
  • Legato Capital Management's Medtronic position peaked at $1.11M in Q2 2021.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Legato Capital Management's 13F filing for Q3 2021, filed 9 Nov 2021.